发明名称 |
Calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-(phosphonooxy) propylcarbamate |
摘要 |
Form (I) calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[ [(4-aminophenyl)sulfonyl] (isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate of formula (I) having substantially the same X-ray powder diffraction pattern as Figure 1, wherein the powder diffraction pattern is obtained with a diffractometer using copper K a X-radiation and the processes for its preparation, and to its use in the treatment of diseases caused by retroviruses are disclosed.
|
申请公布号 |
NZ509291(A) |
申请公布日期 |
2003.05.30 |
申请号 |
NZ19990509291 |
申请日期 |
1999.07.15 |
申请人 |
GLAXO GROUP LIMITED |
发明人 |
ARMITAGE, IAN GORDON;SEARLE, ANDREW DAVID;SINGH, HARDEV |
分类号 |
A61K31/665;A61K38/55;A61P31/12;A61P31/14;A61P31/18;A61P37/04;C07F9/655;(IPC1-7):C07F9/655 |
主分类号 |
A61K31/665 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|